Christina Shafer insider trades

Open-market stock purchases and sales by Christina Shafer, Chief Commercial Officer at Neurogene Inc, from SEC Form 4 filings since Nov 9, 2022.

Recent trades

DateStockTradeValue
May 5, 2026NGNE Neurogene IncBought (not open market)—

Companies traded

  • NGNE Neurogene Inc: other filings, last May 5, 2026
  • MRNS Marinus Pharmaceuticals, Inc: 4 sales, last Feb 11, 2025

Get free alerts when Christina Shafer files a new trade →